STRATEGIES TO COUNTERACT RESISTANCE MECHANISMS IN CAR+ T-CELL-BASED IMMUNOTHERAPY FOR TRIPLE-NEGATIVE BREAST CANCER

$1,023,084FY2016Department of the ArmyDOD

The General Hospital Corporation

Investigators